Increased fracture risk was particularly dangerous during the first two weeks after therapy, when the relative risk was seven times higher than patients in patients on a short-acting opioid.
After the initial two week period, the fracture risk associated with short-acting opioids dropped off but still remained greater than with NSAID therapy.
Read the Internal Medicine News report on short-acting opioids.
Read more on anesthesia:
–Maryland Anesthesiologist Arrested for Alleged Narcotic Distribution
–FDA Accepts Drug Application for Postsurgical Pain Management
–Blocking Receptor Might Help Control Post-Surgery Pain or Inflammation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.